Salmon SE - Search Results

1

Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.

Alberts DS, Chen HS, Salmon SE, Surwit EA, Young L, Moon TE, Meyskens FL Jr. Alberts DS, et al. Among authors: salmon se. Cancer Chemother Pharmacol. 1981;6(3):279-85. doi: 10.1007/BF00256981. Cancer Chemother Pharmacol. 1981. PMID: 6172215 Free article.

2

Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.

Ludwig R, Alberts DS, Miller TP, Salmon SE. Ludwig R, et al. Among authors: salmon se. Cancer Chemother Pharmacol. 1984;12(3):135-41. doi: 10.1007/BF00256533. Cancer Chemother Pharmacol. 1984. PMID: 6705130

3

New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.

Salmon SE, Meyskens FL Jr, Alberts DS, Soehnlen B, Young L. Salmon SE, et al. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):1-12. Cancer Treat Rep. 1981. PMID: 7226159 Free article.

4

Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy.

Moon TE, Salmon SE, White CS, Chen HS, Meyskens FL, Durie BG, Alberts DS. Moon TE, et al. Among authors: salmon se. Cancer Chemother Pharmacol. 1981;6(3):211-8. doi: 10.1007/BF00256973. Cancer Chemother Pharmacol. 1981. PMID: 7318144 Free article.

5

Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.

Alberts DS, Salmon SE, Chen HS, Moon TE, Young L, Surwit EA. Alberts DS, et al. Among authors: salmon se. Cancer Chemother Pharmacol. 1981;6(3):253-64. doi: 10.1007/BF00256978. Cancer Chemother Pharmacol. 1981. PMID: 7318146

6

Clinical correlations of drug sensitivity in the human tumor stem cell assay.

Salmon SE, Alberts DS, Durie BG, Meyskens FL, Jones SE, Soehnlen B, Chen HS, Moon T. Salmon SE, et al. Recent Results Cancer Res. 1980;74:300-5. doi: 10.1007/978-3-642-81488-4_36. Recent Results Cancer Res. 1980. PMID: 7444146

7

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE. Salmon SE, et al. N Engl J Med. 1978 Jun 15;298(24):1321-7. doi: 10.1056/NEJM197806152982401. N Engl J Med. 1978. PMID: 77475

8

Bleomycin pharmacokinetics in man. I. Intravenous administration.

Alberts DS, Chen HS, Liu R, Himmelstein KJ, Mayersohn M, Perrier D, Gross J, Moon T, Broughton A, Salmon SE. Alberts DS, et al. Among authors: salmon se. Cancer Chemother Pharmacol. 1978;1(3):177-81. doi: 10.1007/BF00253118. Cancer Chemother Pharmacol. 1978. PMID: 86392 No abstract available.

9

Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin.

Alberts DS, Chen HS, Woolfenden JM, Moon TE, Chang SY, Hall JN, Himmelstein KJ, Gross J, Salmon SE. Alberts DS, et al. Among authors: salmon se. Cancer Chemother Pharmacol. 1979;3(1):33-40. doi: 10.1007/BF00254417. Cancer Chemother Pharmacol. 1979. PMID: 93987 No abstract available.

10

Adriamycin (NSC-123127) in the treatment of alkylator-resistant multiple myeloma: a pilot study.

Alberts DS, Salmon SE. Alberts DS, et al. Among authors: salmon se. Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):345-50. Cancer Chemother Rep. 1975. PMID: 1097093 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters